Targeted cancer therapy and its ophthalmic side effects: A review

Shruthi Harish Bindiganavile, Nita Bhat, Andrew G. Lee, Dan S. Gombos, Nagham Al-Zubidi

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Targeted cancer therapy agents are the latest development in cancer therapeutics. Although the spectrum of their use continues to expand, ocular side effects are frequently encountered with the use of cancer therapeutics. This review describes the ocular side effects of targeted cancer therapy agents.

Original languageEnglish (US)
Pages (from-to)6-15
Number of pages10
JournalJournal of Immunotherapy and Precision Oncology
Volume4
Issue number1
DOIs
StatePublished - 2021

Keywords

  • Cancer immunotherapy
  • Immune-related adverse events
  • Ocular side effects

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Immunology
  • Immunology and Allergy

Fingerprint

Dive into the research topics of 'Targeted cancer therapy and its ophthalmic side effects: A review'. Together they form a unique fingerprint.

Cite this